Skip to content
10-K

Annual Report

THERAGENICS CORP

0001188112-13-000590

← back to feed
Filed
Mar 8, 2013 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2012 · Feb 28, 2013 31.05M sh
Shares Diluted FY 2012 · Dec 31, 2012 32.17M sh
Shares Diluted FY 2012 · Dec 31, 2011 33.82M sh
Shares Diluted FY 2012 · Dec 31, 2010 33.49M sh
Stock Repurchased FY 2012 · Dec 31, 2012 $10.38M
Stock Repurchased FY 2012 · Jul 17, 2012 $10.4M
Capex FY 2012 · Dec 31, 2012 $1.92M
Capex FY 2012 · Dec 31, 2011 $2.03M
Capex FY 2012 · Dec 31, 2010 $9.07M
Long Term Debt FY 2012 · Dec 31, 2012 $22M
Cash And Equivalents FY 2012 · Dec 31, 2012 $23.59M
Cash And Equivalents FY 2012 · Dec 31, 2011 $29.55M
Cash And Equivalents FY 2012 · Dec 31, 2010 $29.67M
Cash And Equivalents FY 2012 · Dec 31, 2009 $45.33M
Stockholders Equity FY 2012 · Dec 31, 2012 $76.93M
Stockholders Equity FY 2012 · Dec 31, 2011 $84.12M
Stockholders Equity FY 2012 · Dec 31, 2010 $80.28M
Stockholders Equity FY 2012 · Dec 31, 2009 $77.65M
Current Liabilities FY 2012 · Dec 31, 2012 $5.57M
Current Liabilities FY 2012 · Dec 31, 2011 $29.45M
Total Liabilities FY 2012 · Dec 31, 2012 $28.8M
Total Liabilities FY 2012 · Dec 31, 2011 $31.7M
Current Assets FY 2012 · Dec 31, 2012 $61.55M
Current Assets FY 2012 · Dec 31, 2011 $71.74M
Total Assets FY 2012 · Dec 31, 2012 $105.73M
Total Assets FY 2012 · Dec 31, 2011 $115.82M
Eps Diluted FY 2012 · Dec 31, 2012 −$0.01
Eps Diluted FY 2012 · Dec 31, 2012 $0.07
Eps Diluted FY 2012 · Sep 30, 2012 $0.02
Eps Diluted FY 2012 · Jun 30, 2012 $0.02
Eps Diluted FY 2012 · Mar 31, 2012 $0.03
Eps Diluted FY 2012 · Dec 31, 2011 $0.01
Eps Diluted FY 2012 · Dec 31, 2011 $0.09
Eps Diluted FY 2012 · Sep 30, 2011 $0.03
Eps Diluted FY 2012 · Jun 30, 2011 $0.04
Eps Diluted FY 2012 · Mar 31, 2011 $0.01
Eps Diluted FY 2012 · Dec 31, 2010 $0.06
Eps Basic FY 2012 · Dec 31, 2012 −$0.01
Eps Basic FY 2012 · Dec 31, 2012 $0.07
Eps Basic FY 2012 · Sep 30, 2012 $0.02
Eps Basic FY 2012 · Jun 30, 2012 $0.02
Eps Basic FY 2012 · Mar 31, 2012 $0.03
Eps Basic FY 2012 · Dec 31, 2011 $0.01
Eps Basic FY 2012 · Dec 31, 2011 $0.09
Eps Basic FY 2012 · Sep 30, 2011 $0.03
Eps Basic FY 2012 · Jun 30, 2011 $0.04
Eps Basic FY 2012 · Mar 31, 2011 $0.01
Eps Basic FY 2012 · Dec 31, 2010 $0.06
Sga Expense FY 2012 · Dec 31, 2012 $22.26M
Sga Expense FY 2012 · Dec 31, 2011 $22.69M
Sga Expense FY 2012 · Dec 31, 2010 $24.01M
Rd Expense FY 2012 · Dec 31, 2012 $1.13M
Rd Expense FY 2012 · Dec 31, 2011 $1.65M
Rd Expense FY 2012 · Dec 31, 2010 $1.94M
Net Income FY 2012 · Dec 31, 2012 −$323K
Net Income FY 2012 · Dec 31, 2012 $2.14M
Net Income FY 2012 · Sep 30, 2012 $690K
Net Income FY 2012 · Jun 30, 2012 $838K
Net Income FY 2012 · Mar 31, 2012 $934K
Net Income FY 2012 · Dec 31, 2011 $280K
Net Income FY 2012 · Dec 31, 2011 $3.06M
Net Income FY 2012 · Sep 30, 2011 $1.14M
Net Income FY 2012 · Jun 30, 2011 $1.19M
Net Income FY 2012 · Mar 31, 2011 $458K
Net Income FY 2012 · Dec 31, 2010 $2.07M
Operating Income FY 2012 · Dec 31, 2012 $3.77M
Operating Income FY 2012 · Dec 31, 2011 $5.5M
Operating Income FY 2012 · Dec 31, 2010 $3.89M
Gross Profit FY 2012 · Dec 31, 2012 $6.48M
Gross Profit FY 2012 · Dec 31, 2012 $30.54M
Gross Profit FY 2012 · Sep 30, 2012 $7.44M
Gross Profit FY 2012 · Jun 30, 2012 $8.01M
Gross Profit FY 2012 · Mar 31, 2012 $8.61M
Gross Profit FY 2012 · Dec 31, 2011 $7.21M
Gross Profit FY 2012 · Dec 31, 2011 $32.66M
Gross Profit FY 2012 · Sep 30, 2011 $8.77M
Gross Profit FY 2012 · Jun 30, 2011 $8.71M
Gross Profit FY 2012 · Mar 31, 2011 $7.97M
Gross Profit FY 2012 · Dec 31, 2010 $33.03M
Cost Of Revenue FY 2012 · Dec 31, 2012 $52.02M
Cost Of Revenue FY 2012 · Dec 31, 2011 $50.07M
Cost Of Revenue FY 2012 · Dec 31, 2010 $49.16M
Short Term Debt FY 2012 · Dec 31, 2011 $23.67M